DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Benzbromarone
Benzbromarone
Acute Toxicity of Cyanide in Aerobic Respiration: Theoretical and Experimental Support for Murburn Explanation
Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
(12) Patent Application Publication (10) Pub. No.: US 2013/0059868 A1 Miner Et Al
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Guaiacol As a Drug Candidate for Treating Adult Polyglucosan Body Disease
Metabolic Epoxidation Is a Critical Step for the Development of Benzbromarone-Induced Hepatotoxicity
Letters to the Editor Benzbromarone Withdrawn from Table I
Repurposing Benzbromarone for Pulmonary Arterial Hypertension: Can Channelling the Past Deliver the Therapy of the Future?
Report on the Deliberation Results May 8, 2013 Evaluation And
Multidrug-Resistance Protein 5 Is a Multispecific Organic Anion Transporter Able to Transport Nucleotide Analogs Jan Wijnholds*, Carla A
Gout Treatment Factsheet
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
2020 American College of Rheumatology Guideline for the Management of Gout
The Role of Abcg2 in Drug Active Transport in Milk
TITLE PAGE Identification of Epoxide-Derived Metabolite(S) Of
In Vitro Model for Hepatotoxicity Studies Based on Primary Human Hepatocyte Cultivation in a Perfused 3D Bioreactor System
Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: an Evidence-Based Update
Weird Thyroid Function Tests, Difficult Gout, and Dementia
Top View
Coordinate Regulation of Adenosine Deaminase
Free PDF Download
New Inhibitory Effects of Cilnidipine on Microglial P2X7 Receptors and IL-1Β Release: an Involvement in Its Alleviating Effect on Neuropathic Pain
Customs Tariff - Schedule Xxi - 1
Metabolomics Analysis Elucidates Unique Influences on Purine
Novel Agent Targets Osteoarthritic Knee Pain
Benzbromarone?
JIA Guideline Appendix 4
Supplementary Tables and Appendices
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
GOUT Is a Clinical Syndrome Resulting from The
Hypoglycemic Effect of Prolamin from Cooked Foxtail Millet
ICD-10-CM Drug FY2021
Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor S
Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine
(19) United States (12) Patent Application Publication (10) Pub
209203Orig1s000
Orotic Aciduria
In Vitro Transport of Methotrexate by Drosophila Multidrug Resistance-Associated Protein
Benzbromarone in the Treatment of Gout
EASL Clinical Practice Guidelines: Drug-Induced Liver Injuryq
Electrochemical Analysis of Uric Acid Excretion to the Intestinal Lumen: Effect of Serum Uric Acid-Lowering Drugs and 5/6 Nephrectomy on Intestinal Uric Acid Levels
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Effective Uric Acid-Lowering Treatment for Hypertensive Patients with Hyperuricemia
Antihyperuricemics Review – February 2021 Page 2 | Proprietary Information
Identification of Febuxostat As a New Strong ABCG2 Inhibitor
Gout Treatment and Management Guidelines Acute Gout Management - Pharmacological Acute Management – Non
Benzbromarone Pharmacokinetics and Pharmacodynamics in Different Cytochrome P450 2C9 Genotypes